UW Health is one of 100 clinical trial sites in the United States using a new antibody cocktail to treat coronavirus patients. Dr. William Hartman, UW Health’s principal investigator for the Regeneron clinical trial, joins Live at Four to talk about the experimental treatment.
University Communications